trending Market Intelligence /marketintelligence/en/news-insights/trending/sux1sklv6gq0oldxzkcuvg2 content esgSubNav
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

BeyondSpring appoints CFO

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


BeyondSpring appoints CFO

New York's BeyondSpring Inc. appointed Edward Liu CFO.

Liu has more than a decade of senior banking experience, having served at J.P. Morgan and Jefferies. Prior to joining BeyondSpring, he served as partner and executive director at Epiphron Capital, an early investor in the company.

"His distinct blend of healthcare and in-depth financial expertise will be a key addition to the leadership team's collective experience as we advance toward our goal to submit New Drug Applications in China around year-end 2018/early 2019, and in the U.S. beginning in 2019," BeyondSpring CEO Lan Huang said in a statement.

BeyondSpring develops therapies for cancer using immuno-oncology.

BeyondSpring's lead asset, Plinabulin, is in a phase 3 clinical trial as a direct anticancer agent in non-small cell lung cancer and two phase 2/3 clinical programs in the prevention of chemotherapy-induced neutropenia.